Spatiotemporal identification of therapeutic markers <i>via</i> dual-targeted SERS bioprobes for assessing breast cancer progression
A dual-targeted SERS strategy enables ultrasensitive detection of PD-L1 and HER2 in breast cancer. With machine learning-assisted SERS, it achieves a spatiotemporal heterogeneity accuracy of >94%.
Institutions
- Zhejiang Chinese Medical University (CN)
- Chinese Academy of Sciences (CN)
- Zhejiang Cancer Hospital (CN)
- Ningbo Institute of Industrial Technology (CN)
Publication Details
- Journal
- Materials Chemistry Frontiers
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1039/d5qm00808e
- Primary Topic
- Spectroscopy Techniques in Biomedical and Chemical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00